Close Menu
  • Home
  • Economic News
  • Stock Market
  • Real Estate
  • Crypto
  • Investment
  • Personal Finance
  • Retirement
  • Banking

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Firedancer Launches Bug Bounty Program Offering 2x Rewards

October 23, 2026

Can LG CNS Partnership Push LINK Higher?

October 23, 2026

AmEx Adds Airbnb Perks, Tightens Platinum Hotel Credit Rules

October 23, 2026
Facebook X (Twitter) Instagram
  • Contact Us
  • Privacy Policy
  • Terms Of Service
Saturday, November 21
Doorpickers
Facebook X (Twitter) Instagram
  • Home
  • Economic News
  • Stock Market
  • Real Estate
  • Crypto
  • Investment
  • Personal Finance
  • Retirement
  • Banking
Doorpickers
Home»Stock Market»US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By Reuters
Stock Market

US FDA flags dosing risks from compounded versions of Novo’s weight-loss drug By Reuters

August 6, 2024No Comments2 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

The U.S. Food and Drug Administration issued a warning on Friday regarding dosing errors associated with compounded versions of Novo Nordisk’s weight-loss and diabetes medications. The FDA has received reports of adverse events, some resulting in hospitalization, which may be linked to overdoses caused by patients incorrectly self-administering the compounded drugs and healthcare providers misjudging doses.

The FDA emphasized the heightened risk to patients when using compounded drugs, as they may contain additional ingredients that could contribute to medication errors. Healthcare providers and compounders are urged to provide the appropriate syringe size and educate patients on how to accurately measure their doses to prevent overdosing.

An overdose of these drugs could lead to severe side effects such as nausea, vomiting, and low blood sugar levels. The surge in demand has led to a significant shortage and a thriving global market for cheaper, and sometimes counterfeit, versions of these medications.

The FDA has also expressed concerns about the prevalence of fake versions of Novo’s diabetes drug Ozempic and other weight loss medications, including Novo’s Wegovy and Eli Lilly’s Zepbound.

© Reuters. FILE PHOTO: Injection pens and boxes of Novo Nordisk's weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, November 21, 2023. REUTERS/Victoria Klesty/Illustration/File Photo

Semaglutide, the main component in Wegovy and Ozempic, belongs to the GLP-1 class of drugs, which help regulate blood sugar levels and induce a sensation of fullness. Wegovy is available in single-dose pre-filled pens for once-weekly dosing, while Ozempic comes in multiple-dose pre-filled pens for single-patient use, designed for weekly dosing.

compounded dosing drug FDA flags Novos Reuters Risks versions weightloss
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Can a Seller Back Out of a Contract? Rules and Risks

October 13, 2026

Investment Property Red Flags to Watch For

October 7, 2026

FDA Commissioner Nominee Says Every Vaccine On US Market Is Safe, Effective

September 27, 2026
Add A Comment
Leave A Reply Cancel Reply

Top Posts

Russia reacts to the US’s ‘new turn of escalation’

November 18, 20247 Views

River Integrates LayerZero to Power Native Omni-Chain Stablecoin Liquidity

August 26, 20257 Views

Report Finds US Military Lacks Ability To Defeat China, Suggests Cold War Style Defense Spending

July 31, 20248 Views
Stay In Touch
  • Facebook
  • YouTube
  • TikTok
  • WhatsApp
  • Twitter
  • Instagram
Latest
Crypto

Firedancer Launches Bug Bounty Program Offering 2x Rewards

October 23, 20260
Crypto

Can LG CNS Partnership Push LINK Higher?

October 23, 20260
Personal Finance

AmEx Adds Airbnb Perks, Tightens Platinum Hotel Credit Rules

October 23, 20260
Facebook X (Twitter) Instagram Pinterest
  • Contact Us
  • Privacy Policy
  • Terms Of Service
© 2026 doorpickers.com - All rights reserved

Type above and press Enter to search. Press Esc to cancel.